Clinical Trials Directory

Trials / Completed

CompletedNCT06204133

Model Study on Cervical Cancer Screening Strategies and Risk Prediction

Status
Completed
Phase
Study type
Observational
Enrollment
1,112,846 (actual)
Sponsor
Fujian Maternity and Child Health Hospital · Academic / Other
Sex
Female
Age
25 Years – 64 Years
Healthy volunteers
Accepted

Summary

By collecting non-image medical data of women undergoing cervical screening in multiple centers in China, including age, HPV infection status, HPV infection type, TCT results, and colposcopy biopsy pathology results, a multi-source heterogeneous cervical lesion collaborative research big data platform was established. Based on artificial intelligence (AI) machine learning, cervical lesion screening features are refined, a multi-modal cervical cancer intelligent screening prediction and risk triage model is constructed, and its clinical application value is preliminarily explored.

Detailed description

By collecting non-image medical data of women undergoing cervical screening in multiple centers in China, including age, HPV infection status, HPV infection type, TCT results, and colposcopy biopsy pathology results, a multi-source heterogeneous cervical lesion collaborative research big data platform was established. Based on artificial intelligence (AI) machine learning, cervical lesion screening features are refined, a multi-modal cervical cancer intelligent screening prediction and risk triage model is constructed, and its clinical application value is preliminarily explored. The effect of clinical application of the model was evaluated by internal data from Fujian Province and external data from several other regions in China.

Conditions

Interventions

TypeNameDescription
OTHERArtificial intelligence model buildingUsing non-image medical data of cervical lesions and clinical pathology results in different medical institutions, machine learning is adopted to establish multiple multi-modal cervical cancer intelligent screening prediction models. This method was used to analyze the prediction performance of the multi-modal cervical cancer intelligent screening prediction and risk triage model, and to evaluate and optimize the self-learning ability of the established multi-modal cervical cancer intelligent screening prediction model.

Timeline

Start date
2023-11-01
Primary completion
2024-04-30
Completion
2024-06-30
First posted
2024-01-12
Last updated
2024-07-22

Locations

7 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06204133. Inclusion in this directory is not an endorsement.